Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL327494 | 0.72 | — | — | |
| SCHEMBL1245013 | 0.71 | ALDH1A1 (0.41) | USP2 | |
| SCHEMBL10059147 | 0.70 | PIK3CD (0.34) | USP2ALOX15 | |
| SCHEMBL2918731 | 0.69 | — | — | |
| SCHEMBL9869071 | 0.68 | — | — | |
| SCHEMBL6825745 | 0.67 | NAMPT (0.34) | — | |
| SCHEMBL14030019 | 0.67 | SLC6A4 (0.32) | — | |
| SCHEMBL5468024 | 0.67 | NAMPT (0.36) | — | |
| SCHEMBL4107607 | 0.67 | NAMPT (0.36) | — | |
| SCHEMBL11434822 | 0.67 | NAMPT (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11090413-B2 | Modified alginates for anti-fibrotic materials and applications | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-08-17 | — | — | US | disclosed |
| US-20190184067-A1 | MODIFIED ALGINATES FOR ANTI-FIBROTIC MATERIALS AND APPLICATIONS | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2019-06-20 | — | — | US | disclosed |
| US-20170226232-A1 | MODIFIED ALGINATES FOR ANTI-FIBROTIC MATERIALS AND APPLICATIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2017-08-10 | — | — | US | disclosed |
| WO-1991011448-A1 | THERAPEUTIC AGENTS | THE BOOTS COMPANY PLC (GB) | 1991-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226232-A1 | MODIFIED ALGINATES FOR ANTI-FIBROTIC MATERIALS AND APPLICATIONS | ALG1, FIBP, COL2A1 | USP2 1391/4885ALOX15 1044/4885 |
| US-11090413-B2 | Modified alginates for anti-fibrotic materials and applications | ALG1, FIBP, COL2A1 | USP2 1391/4885ALOX15 1044/4885 |
| US-20190184067-A1 | MODIFIED ALGINATES FOR ANTI-FIBROTIC MATERIALS AND APPLICATIONS | ALG1, FIBP, COL2A1 | USP2 1391/4885ALOX15 1044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.